| Beyond the glutamate N-methyl D-aspartate receptor in major depressive disorder: The mTOR signaling pathway | Beata KAROLEWİCZ, Mesut ÇETİN, Feyza ARICIOĞLU | 1–6 |
| Depression and cardiovascular disease: The need for improved case definition | Jorge PARADA PEREZ | 7–10 |
| The effects of reboxetine and venlafaxine on ECG variables in depressed patients | Salih Saygın EKER, Cengiz AKKAYA, Şengül CANGÜR, Selçuk KIRLI, Uğur YUVANÇ, Aslı SARANDOL | 11–17 |
| The efficacy of venlafaxine in treatment of depression in Parkinson`s disease | Sebahat Dilek TORUN, Fuat TORUN, Kemal BAYÜLKEM | 18–23 |
| Katekol-O-metiltransferaz geni Val158Met polimorfizminin şizofreni hastalarındaki bilişsel işlevlere etkileri | Filiz KARADAĞ, Özlem AY İZCİ, Tuba GÖKDOĞAN EDGÜNLÜ, M. Emin ERDAL, Gülfizar VARMA SÖZERİ, Neslihan LEVENT, Çiğdem TEKKANAT, Hasan HERKEN | 24–32 |
| Risperidone treatment in preschool children with disruptive behavior disorders: A chart review study | Murat COŞKUN, Süleyman Salih ZOROĞLU, Mücahit ÖZTÜRK | 33–41 |
| P50 sensory gating in children and adolescents with ADHD and effects of methylphenidate administration on P50 sensory gating | İbrahim DURUKAN, Dursun KARAMAN, Koray KARA, Murat ERDEM, Oğuzhan ÖZ, Mehmet YÜCEL, Zeki ODABAŞI | 42–48 |
| Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey | Yıldırım ÇINAR, Nazan BİLGEL, Hakan DEMİRCİ | 49–57 |
| Poison information center data about druginduced acute dystonic reactions | Yeşim TUNÇOK, M. Aylin ARICI, Durgül ÖZDEMİR, Şule KALKAN, Kubilay ORANSAY, Sinem EVCİM | 58–63 |
| Pregabalin abuse: A case report | Filiz ÖZDEMİROĞLU ALYANAK, İlhan YARGIÇ | 64–66 |
| Çok yüksek doz ketiapin alımı ile intihar girişimi | Numan KONUK, ALPTEKİN ÇETİN | 67–69 |
| Metoklopramid kullanımına bağlı gelişen akut distoni olgusu | Nuray ULUĞ CAN, Mehmet ULUĞ | 70–72 |